Effect of Cell Age on Uptake and Toxicity of Nanoparticles: The Overlooked Factor at the Nanobio Interface-Reference-Cited by-同舟云学术

Effect of Cell Age on Uptake and Toxicity of Nanoparticles: The Overlooked Factor at the Nanobio Interface

Published:2019-10-21 Issue:43 Volume:11 Page:39672-39687
ISSN:1944-8244
Container-title:ACS Applied Materials & Interfaces
language:en
Short-container-title:ACS Appl. Mater. Interfaces

Author:

Foroozandeh Parisa¹,Aziz Azlan Abdul¹²,Mahmoudi Morteza³^ORCID

Affiliation:

1. School of Physics, Universiti Sains Malaysia, 11800 Penang, Malaysia

2. Nano-Biotechnology Research and Innovation (NanoBRI), Institute for Research in Molecular Medicine (INFORMM), Universiti Sains Malaysia, 11800 Penang, Malaysia

3. Precision Health Program, Michigan State University, East Lansing, Michigan 48824, United States

Funder

Michigan State University

Universiti Sains Malaysia

Publisher

American Chemical Society (ACS)

Subject

General Materials Science

Link

https://pubs.acs.org/doi/pdf/10.1021/acsami.9b15533

Reference67 articles.

1. Debugging Nano–Bio Interfaces: Systematic Strategies to Accelerate Clinical Translation of Nanotechnologies

2. Cancer nanomedicine: progress, challenges and opportunities

3. Nanoparticle-Based Medicines: A Review of FDA-Approved Materials and Clinical Trials to Date

Cited by 32 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Red blood cell derived nanocarrier drug delivery system: A promising strategy for tumor therapy;Interdisciplinary Medicine;2024-06-21

2. Nanocarriers address intracellular barriers for efficient drug delivery, overcoming drug resistance, subcellular targeting and controlled release;Advanced Drug Delivery Reviews;2024-04

3. Minimum Information for Conducting and Reporting In Vitro Intracellular Infection Assays;ACS Infectious Diseases;2024-01-31

4. Cellular senescence and nanoparticle-based therapies: Current developments and perspectives;Nanotechnology Reviews;2024-01-01

5. Cellular uptake, intracellular behavior, and acute/sub-acute cytotoxicity of a PEG-modified quantum dot with promising in-vivo biomedical applications;Heliyon;2023-09